Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Application of 200 kHz Tumor Treating Fields (TTFields) in Patients With Infratentorial High-Grade Glioma: Case Series.

Brain tumor research and treatment·2026
Same journal

Primary Intradural Extramedullary Ewing Sarcoma of the Thoracic Spine With Leptomeningeal and Brain Metastases: A Case Report and Literature Review.

Brain tumor research and treatment·2026
Same journal

<i>In Silico</i> Prediction of EZHIP Post-Translational Modification Sites and Small-Molecule High-Throughput Screening for Quantitative EZHIP Modulation.

Brain tumor research and treatment·2026
Same journal

Prognostic Importance of Histomolecular Subtyping of Central Nervous System Gliomas in Low and Middle-Income Countries.

Brain tumor research and treatment·2026
Same journal

Survival Outcomes of Gamma Knife Radiosurgery in <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer Patients With 1-4 Versus 5-10 Brain Metastases: A Vietnamese Study.

Brain tumor research and treatment·2026
Same journal

Prognostic Value of EGFR Mutation Subtypes After Linac-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis From EGFR-Mutated Non-Small Cell Lung Cancer.

Brain tumor research and treatment·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

672

Trends in Developing Extracellular Vesicle-Based Therapeutics.

Jaewook Lee1

  • 1Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang, Korea. jaewook8@postech.ac.kr.

Brain Tumor Research and Treatment
|August 7, 2024
PubMed
Summary
This summary is machine-generated.

Extracellular vesicles (EVs) show promise as next-generation therapeutics due to their biological activities. This review covers EV advantages, limitations, and key considerations for developing EV-based therapies.

Keywords:
Clinical trials.Extracellular vesiclesManufacturingNon-clinical studiesQuality controlTherapeutics

More Related Videos

Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

280
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.0K

Related Experiment Videos

Last Updated: Jun 17, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

672
Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

280
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.0K

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Cell Biology

Background:

  • Extracellular vesicles (EVs) are nano-sized, lipid bilayer-enclosed vesicles released by cells for intercellular communication.
  • EVs contain biologically active molecules, positioning them as potential next-generation therapeutics for various diseases.

Purpose of the Study:

  • To review the advantages and limitations of extracellular vesicles (EVs) as therapeutic agents.
  • To outline critical considerations for the development of EV-based therapeutics.
  • To present current development cases of EV-based therapeutics.

Main Methods:

  • This review synthesizes information from existing literature on extracellular vesicle biology and therapeutic development.
  • Key aspects discussed include manufacturing, quality control, preclinical studies, and clinical trial considerations for EVs.

Main Results:

  • EVs offer favorable characteristics for therapeutic development but also present significant limitations.
  • Successful development requires careful attention to manufacturing, quality control, and regulatory pathways.

Conclusions:

  • Extracellular vesicles hold substantial therapeutic potential, but overcoming development challenges is crucial for clinical translation.
  • Ongoing research and biopharmaceutical company efforts highlight the growing interest and investment in EV-based therapies.